Insider Transactions in Q1 2025 at Enhabit, Inc. (EHAB)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2025
|
Collin Mc Quiddy Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,096
-100.0%
|
$8,768
$8.58 P/Share
|
|
Mar 07
2025
|
Tanya Renee Marion Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,457
+22.64%
|
$139,656
$8.02 P/Share
|
|
Mar 07
2025
|
Dylan C Black General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
19,452
+29.19%
|
$155,616
$8.02 P/Share
|
|
Mar 07
2025
|
Ryan Solomon Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,173
+17.58%
|
$249,384
$8.02 P/Share
|
|
Mar 07
2025
|
Barbara Ann Jacobsmeyer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
133,541
+18.75%
|
$1,068,328
$8.02 P/Share
|
|
Mar 07
2025
|
Collin Mc Quiddy Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+50.0%
|
$47,888
$8.02 P/Share
|
|
Mar 07
2025
|
Julie Diane Jolley EVP of Home Health Operations |
BUY
Grant, award, or other acquisition
|
Direct |
24,439
+20.94%
|
$195,512
$8.02 P/Share
|
|
Mar 06
2025
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,604
-5.82%
|
$20,832
$8.02 P/Share
|
|
Mar 06
2025
|
Tanya Renee Marion Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,638
+14.57%
|
$61,104
$8.02 P/Share
|
|
Mar 06
2025
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,272
-8.98%
|
$10,176
$8.02 P/Share
|
|
Mar 06
2025
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,287
+23.23%
|
$34,296
$8.02 P/Share
|
|
Mar 06
2025
|
Dylan C Black General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,775
-9.1%
|
$22,200
$8.02 P/Share
|
|
Mar 06
2025
|
Dylan C Black General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,638
+20.03%
|
$61,104
$8.02 P/Share
|
|
Mar 06
2025
|
Ryan Solomon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
270
-0.23%
|
$2,160
$8.02 P/Share
|
|
Mar 06
2025
|
Ryan Solomon Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
910
+0.78%
|
$7,280
$8.02 P/Share
|
|
Mar 06
2025
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,833
-2.38%
|
$86,664
$8.02 P/Share
|
|
Mar 06
2025
|
Barbara Ann Jacobsmeyer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,822
+5.75%
|
$222,576
$8.02 P/Share
|
|
Mar 06
2025
|
Collin Mc Quiddy Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-29.7%
|
$3,704
$8.02 P/Share
|
|
Mar 06
2025
|
Collin Mc Quiddy Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,559
+50.0%
|
$12,472
$8.02 P/Share
|
|
Mar 06
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,377
-4.06%
|
$19,016
$8.02 P/Share
|
|
Mar 06
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
7,092
+10.81%
|
$56,736
$8.02 P/Share
|
|
Mar 06
2025
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,924
-4.13%
|
$23,392
$8.02 P/Share
|
|
Mar 06
2025
|
Julie Diane Jolley EVP of Home Health Operations |
BUY
Grant, award, or other acquisition
|
Direct |
8,510
+10.74%
|
$68,080
$8.02 P/Share
|
|
Mar 01
2025
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,997
-4.03%
|
$143,976
$8.37 P/Share
|
|
Mar 01
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
3,041
-5.58%
|
$24,328
$8.37 P/Share
|
|
Mar 01
2025
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,148
-10.41%
|
$9,184
$8.37 P/Share
|
|
Mar 01
2025
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,821
-5.78%
|
$30,568
$8.37 P/Share
|
|
Mar 01
2025
|
Dylan C Black General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,609
-10.24%
|
$20,872
$8.37 P/Share
|
|
Mar 01
2025
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,374
-8.33%
|
$26,992
$8.37 P/Share
|
|
Feb 25
2025
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-0.85%
|
$2,768
$8.26 P/Share
|
|
Feb 25
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-0.61%
|
$2,672
$8.26 P/Share
|
|
Feb 25
2025
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
614
-0.92%
|
$4,912
$8.26 P/Share
|
|
Feb 25
2025
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,973
-1.76%
|
$63,784
$8.26 P/Share
|
|
Jan 10
2025
|
Mark W Ohlendorf Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,404
+10.92%
|
$16,828
$7.8 P/Share
|
|
Jan 10
2025
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,404
+4.23%
|
$16,828
$7.8 P/Share
|
|
Jan 10
2025
|
Stuart M Mcguigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,404
+4.66%
|
$16,828
$7.8 P/Share
|
|
Jan 10
2025
|
Barry P. Schochet Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,045
+6.63%
|
$21,315
$7.8 P/Share
|
|
Jan 10
2025
|
Gregory S Rush Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,205
+5.96%
|
$22,435
$7.8 P/Share
|
|
Jan 10
2025
|
Erin Hoeflinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,045
+5.6%
|
$21,315
$7.8 P/Share
|
|
Jan 10
2025
|
Jeffrey Bolton Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,808
+4.46%
|
$33,656
$7.8 P/Share
|
|
Jan 01
2025
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,458
-2.5%
|
$24,206
$7.81 P/Share
|
|
Jan 01
2025
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,834
-1.8%
|
$117,838
$7.81 P/Share
|
|
Jan 01
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,687
-1.5%
|
$11,809
$7.81 P/Share
|
|
Jan 01
2025
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,800
-2.13%
|
$12,600
$7.81 P/Share
|